435 related articles for article (PubMed ID: 27676224)
21. Antimicrobial mechanism of theaflavins: They target 1-deoxy-D-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
Hui X; Yue Q; Zhang DD; Li H; Yang SQ; Gao WY
Sci Rep; 2016 Dec; 6():38945. PubMed ID: 27941853
[TBL] [Abstract][Full Text] [Related]
22. A computational study of the molecular basis of antibiotic resistance in a DXR mutant.
Krebs FS; Esque J; Stote RH
J Comput Aided Mol Des; 2019 Oct; 33(10):927-940. PubMed ID: 31654265
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents.
Ponaire S; Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M
Eur J Med Chem; 2012 May; 51():277-85. PubMed ID: 22405649
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory Activity of Plant Essential Oils against
Yan G; Zhu BR; Tian FL; Hui X; Li H; Li YM; Gao WY
Molecules; 2019 Jul; 24(14):. PubMed ID: 31295807
[TBL] [Abstract][Full Text] [Related]
25. The methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis as a target for the development of new drugs against tuberculosis.
Obiol-Pardo C; Rubio-Martinez J; Imperial S
Curr Med Chem; 2011; 18(9):1325-38. PubMed ID: 21366531
[TBL] [Abstract][Full Text] [Related]
26. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake.
Brown AC; Parish T
BMC Microbiol; 2008 May; 8():78. PubMed ID: 18489786
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies.
Deng L; Diao J; Chen P; Pujari V; Yao Y; Cheng G; Crick DC; Prasad BV; Song Y
J Med Chem; 2011 Jul; 54(13):4721-34. PubMed ID: 21561155
[TBL] [Abstract][Full Text] [Related]
28. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
Dhiman RK; Schaeffer ML; Bailey AM; Testa CA; Scherman H; Crick DC
J Bacteriol; 2005 Dec; 187(24):8395-402. PubMed ID: 16321944
[TBL] [Abstract][Full Text] [Related]
29. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.
Ferreras JA; Ryu JS; Di Lello F; Tan DS; Quadri LE
Nat Chem Biol; 2005 Jun; 1(1):29-32. PubMed ID: 16407990
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of Brucella abortus deoxyxylulose-5-phosphate reductoisomerase-like (DRL) enzyme involved in isoprenoid biosynthesis.
Pérez-Gil J; Calisto BM; Behrendt C; Kurz T; Fita I; Rodríguez-Concepción M
J Biol Chem; 2012 May; 287(19):15803-9. PubMed ID: 22442144
[TBL] [Abstract][Full Text] [Related]
31. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
Proteau PJ
Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
[TBL] [Abstract][Full Text] [Related]
32. α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues.
Dreneau A; Krebs FS; Munier M; Ngov C; Tritsch D; Lièvremont D; Rohmer M; Grosdemange-Billiard C
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443699
[TBL] [Abstract][Full Text] [Related]
33. Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
Cai G; Deng L; Xue J; Moreno SN; Striepen B; Song Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2158-61. PubMed ID: 23428849
[TBL] [Abstract][Full Text] [Related]
34. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
Singh VK; Ghosh I
FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
[TBL] [Abstract][Full Text] [Related]
35. Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).
Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M
Bioorg Med Chem; 2014 Jul; 22(14):3713-9. PubMed ID: 24890653
[TBL] [Abstract][Full Text] [Related]
36. Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis.
Stirrett KL; Ferreras JA; Jayaprakash V; Sinha BN; Ren T; Quadri LE
Bioorg Med Chem Lett; 2008 Apr; 18(8):2662-8. PubMed ID: 18394884
[TBL] [Abstract][Full Text] [Related]
37. MEPicides: α,β-unsaturated Fosmidomycin
Wang X; Edwards RL; Ball HS; Heidel KM; Brothers RC; Johnson C; Haymond A; Girma M; Dailey A; Roma JS; Boshoff HI; Osbourn DM; Meyers MJ; Couch RD; Odom John AR; Dowd CS
ACS Infect Dis; 2023 Jul; 9(7):1387-1395. PubMed ID: 37310810
[TBL] [Abstract][Full Text] [Related]
38. Pre-steady-state kinetic analysis of 1-deoxy-D-xylulose-5-phosphate reductoisomerase from Mycobacterium tuberculosis reveals partially rate-limiting product release by parallel pathways.
Liu J; Murkin AS
Biochemistry; 2012 Jul; 51(26):5307-19. PubMed ID: 22690952
[TBL] [Abstract][Full Text] [Related]
39. Structural characterization of 1-deoxy-D-xylulose 5-phosphate Reductoisomerase from Vibrio vulnificus.
Ussin NK; Bagnell AM; Offermann LR; Abdulsalam R; Perdue ML; Magee P; Chruszcz M
Biochim Biophys Acta Proteins Proteom; 2018 Dec; 1866(12):1209-1215. PubMed ID: 30278288
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives].
Shtannikov AV; Sergeeva EE; Biketov SF; Ostrovskiĭ DN
Antibiot Khimioter; 2007; 52(7-8):3-9. PubMed ID: 18986018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
